data_2kqt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kqt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.486 ' CG ' HD11 ' D' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.478 ' CG ' HD11 ' A' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.48 HD11 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.48 ' CG ' HD11 ' B' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.481 HD11 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.481 ' CG ' HD11 ' C' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.486 HD11 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.49 ' CG ' HD11 ' D' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.482 HD11 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.482 ' CG ' HD11 ' A' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.486 HD11 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.46 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.486 ' CG ' HD11 ' B' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.488 HD11 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.488 ' CG ' HD11 ' C' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.49 HD11 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.43 ' CG ' HD11 ' D' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.453 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.424 ' CG ' HD11 ' A' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.434 HD11 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.434 ' CG ' HD11 ' B' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.436 HD11 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.448 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.436 ' CG ' HD11 ' C' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.43 HD11 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.455 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.562 ' CG ' HD11 ' D' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.554 HD11 ' CG ' ' B' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.442 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.554 ' CG ' HD11 ' A' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.556 HD11 ' CG ' ' C' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.44 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.556 ' CG ' HD11 ' B' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.555 HD11 ' CG ' ' D' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.555 ' CG ' HD11 ' C' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.562 HD11 ' CG ' ' A' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.467 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.457 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.468 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.538 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.538 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.538 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.538 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.543 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.544 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.544 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.503 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.501 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.401 ' O ' HG13 ' C' ' 42' ' ' ILE . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.486 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . 0.401 HG13 ' O ' ' C' ' 38' ' ' LEU . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.402 ' O ' HG13 ' D' ' 42' ' ' ILE . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.503 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . 0.402 HG13 ' O ' ' D' ' 38' ' ' LEU . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.526 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.526 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.528 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.528 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.528 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.528 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.537 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.54 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.54 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.541 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.541 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.521 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.521 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.522 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.522 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.519 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.519 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.442 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.44 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.445 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.401 HD11 ' CG ' ' C' ' 37' ' ' HIS . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.401 ' CG ' HD11 ' B' ' 38' ' ' LEU . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.402 HD11 ' CG ' ' D' ' 37' ' ' HIS . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.402 ' CG ' HD11 ' C' ' 38' ' ' LEU . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.411 ' O ' HG13 ' A' ' 42' ' ' ILE . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.425 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 38' ' ' LEU . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.425 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.408 ' O ' HG13 ' B' ' 42' ' ' ILE . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . 0.432 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.408 HG13 ' O ' ' B' ' 38' ' ' LEU . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.432 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.407 ' O ' HG13 ' C' ' 42' ' ' ILE . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . 0.437 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . 0.407 HG13 ' O ' ' C' ' 38' ' ' LEU . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.437 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.404 ' O ' HG13 ' D' ' 42' ' ' ILE . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . 0.435 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . 0.404 HG13 ' O ' ' D' ' 38' ' ' LEU . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.435 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 42' ' ' ILE . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.464 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 38' ' ' LEU . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.464 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . 0.468 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.468 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.4 ' O ' HG13 ' C' ' 42' ' ' ILE . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . 0.476 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . 0.4 HG13 ' O ' ' C' ' 38' ' ' LEU . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.476 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . 0.474 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.474 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.422 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.422 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . 0.425 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.425 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . 0.433 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.433 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . 0.432 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.432 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 42' ' ' ILE . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.487 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 38' ' ' LEU . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.487 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.428 ' O ' HG13 ' B' ' 42' ' ' ILE . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . 0.498 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.428 HG13 ' O ' ' B' ' 38' ' ' LEU . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.498 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.429 ' O ' HG13 ' C' ' 42' ' ' ILE . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . 0.504 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . 0.429 HG13 ' O ' ' C' ' 38' ' ' LEU . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.504 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.419 ' O ' HG13 ' D' ' 42' ' ' ILE . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . 0.5 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . 0.419 HG13 ' O ' ' D' ' 38' ' ' LEU . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.5 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 42' ' ' ILE . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.473 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 38' ' ' LEU . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.417 ' O ' HG13 ' B' ' 42' ' ' ILE . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . 0.481 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.417 HG13 ' O ' ' B' ' 38' ' ' LEU . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.481 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.401 ' CG ' HD11 ' B' ' 38' ' ' LEU . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.42 ' O ' HG13 ' C' ' 42' ' ' ILE . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . 0.473 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . 0.42 HG13 ' O ' ' C' ' 38' ' ' LEU . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.473 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.413 ' O ' HG13 ' D' ' 42' ' ' ILE . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . 0.471 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . 0.413 HG13 ' O ' ' D' ' 38' ' ' LEU . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.471 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.486 ' CG ' HD11 ' D' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.478 ' CG ' HD11 ' A' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.48 HD11 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.48 ' CG ' HD11 ' B' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.481 HD11 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.481 ' CG ' HD11 ' C' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.486 HD11 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.49 ' CG ' HD11 ' D' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.482 HD11 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.482 ' CG ' HD11 ' A' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.486 HD11 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.46 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.486 ' CG ' HD11 ' B' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.488 HD11 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.488 ' CG ' HD11 ' C' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.49 HD11 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.43 ' CG ' HD11 ' D' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.424 HD11 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.453 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.424 ' CG ' HD11 ' A' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.434 HD11 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.434 ' CG ' HD11 ' B' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.436 HD11 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.448 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.436 ' CG ' HD11 ' C' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.43 HD11 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.455 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.562 ' CG ' HD11 ' D' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.554 HD11 ' CG ' ' B' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.442 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.554 ' CG ' HD11 ' A' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.556 HD11 ' CG ' ' C' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.44 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.556 ' CG ' HD11 ' B' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.555 HD11 ' CG ' ' D' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.555 ' CG ' HD11 ' C' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.562 HD11 ' CG ' ' A' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.467 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.457 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.468 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.538 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.538 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.538 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.538 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.543 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.543 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.544 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.544 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.503 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.501 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.401 ' O ' HG13 ' C' ' 42' ' ' ILE . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.486 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . 0.401 HG13 ' O ' ' C' ' 38' ' ' LEU . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.402 ' O ' HG13 ' D' ' 42' ' ' ILE . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.503 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . 0.402 HG13 ' O ' ' D' ' 38' ' ' LEU . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.526 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.526 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.528 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.528 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.528 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.528 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.537 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.54 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.54 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.541 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.541 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.521 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.521 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.522 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.522 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.519 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.519 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.442 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.44 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.445 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.401 HD11 ' CG ' ' C' ' 37' ' ' HIS . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.401 ' CG ' HD11 ' B' ' 38' ' ' LEU . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.402 HD11 ' CG ' ' D' ' 37' ' ' HIS . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.402 ' CG ' HD11 ' C' ' 38' ' ' LEU . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.411 ' O ' HG13 ' A' ' 42' ' ' ILE . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.425 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 38' ' ' LEU . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.408 ' O ' HG13 ' B' ' 42' ' ' ILE . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . 0.432 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.408 HG13 ' O ' ' B' ' 38' ' ' LEU . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.432 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.407 ' O ' HG13 ' C' ' 42' ' ' ILE . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.437 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . 0.407 HG13 ' O ' ' C' ' 38' ' ' LEU . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.437 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.404 ' O ' HG13 ' D' ' 42' ' ' ILE . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . 0.435 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . 0.404 HG13 ' O ' ' D' ' 38' ' ' LEU . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.435 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 42' ' ' ILE . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.464 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 38' ' ' LEU . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.464 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . 0.468 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.468 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.4 ' O ' HG13 ' C' ' 42' ' ' ILE . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.476 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . 0.4 HG13 ' O ' ' C' ' 38' ' ' LEU . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.476 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . 0.474 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.474 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.422 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.422 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . 0.425 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.425 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.433 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.433 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . 0.432 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.432 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 42' ' ' ILE . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.487 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 38' ' ' LEU . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.487 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.428 ' O ' HG13 ' B' ' 42' ' ' ILE . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . 0.498 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.428 HG13 ' O ' ' B' ' 38' ' ' LEU . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.498 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.429 ' O ' HG13 ' C' ' 42' ' ' ILE . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.504 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . 0.429 HG13 ' O ' ' C' ' 38' ' ' LEU . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.504 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.419 ' O ' HG13 ' D' ' 42' ' ' ILE . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . 0.5 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . 0.419 HG13 ' O ' ' D' ' 38' ' ' LEU . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.5 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 42' ' ' ILE . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.473 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 38' ' ' LEU . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.473 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.417 ' O ' HG13 ' B' ' 42' ' ' ILE . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . 0.481 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.417 HG13 ' O ' ' B' ' 38' ' ' LEU . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.481 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.401 ' CG ' HD11 ' B' ' 38' ' ' LEU . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.42 ' O ' HG13 ' C' ' 42' ' ' ILE . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.473 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . 0.42 HG13 ' O ' ' C' ' 38' ' ' LEU . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.473 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.413 ' O ' HG13 ' D' ' 42' ' ' ILE . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . 0.471 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . 0.413 HG13 ' O ' ' D' ' 38' ' ' LEU . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.471 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.99 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.99 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.99 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.99 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.99 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.99 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.99 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.99 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.99 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.99 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.99 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.99 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.99 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.99 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.458 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.99 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.453 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.99 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.99 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.99 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.99 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.99 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.99 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.99 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.99 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.99 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.99 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.99 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.99 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.99 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.99 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.99 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.99 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.99 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.99 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.99 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.99 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.99 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.99 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.99 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.453 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.99 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.459 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.99 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.99 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.99 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.99 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.99 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.99 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.99 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.99 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.99 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.99 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.99 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.99 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.99 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.99 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.99 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.99 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.99 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.99 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.99 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.99 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.99 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.99 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.99 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.459 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.99 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.457 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.99 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.99 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.99 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.99 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.99 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.99 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.99 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.99 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.99 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.99 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.99 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.99 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.99 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.99 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.99 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.99 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.99 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.99 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.99 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.99 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.99 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.99 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.99 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.457 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.99 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.458 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.99 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.99 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.99 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.99 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.99 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.99 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.99 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.99 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.99 109.334 -178.89 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.99 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.99 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.99 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.99 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.99 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.99 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.99 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.99 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.99 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.99 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.99 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.99 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.99 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.99 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.99 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.463 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.99 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.455 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.99 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.99 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.99 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.99 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.99 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.99 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.99 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.99 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.99 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.99 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.99 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.99 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.99 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.99 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.99 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.99 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.99 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.99 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.99 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.99 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.99 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.99 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.99 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.455 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.99 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.46 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.99 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.449 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.99 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.99 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.99 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.99 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.99 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.99 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.99 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.99 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.99 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.99 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.99 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.99 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.99 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.99 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.99 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.99 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.99 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.99 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.99 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.99 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.99 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.99 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.46 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.99 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.465 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.99 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.99 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.99 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.99 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.99 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.99 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.99 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.99 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.99 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.99 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.99 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.99 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.99 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.99 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.99 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.99 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.99 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.99 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.99 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.99 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.99 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.99 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.99 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.465 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.99 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.463 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.99 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.99 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.99 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.99 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.99 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.99 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.99 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.99 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.99 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.99 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.99 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.99 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.99 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.99 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.99 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.99 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.99 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.99 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.99 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.99 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.99 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.99 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.407 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.99 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.403 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.99 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.99 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.99 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.99 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.99 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.99 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.99 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.99 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.99 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.99 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.99 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.99 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.99 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.99 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.99 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.99 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.99 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.99 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.99 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.99 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.99 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.99 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.99 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.403 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.99 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.413 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.99 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.442 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.99 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.99 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.99 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.99 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.99 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.99 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.99 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.99 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.99 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.99 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.99 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.99 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.99 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.99 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.99 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.99 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.99 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.99 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.99 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.99 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.99 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.99 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.413 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.99 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.41 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.99 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.99 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.99 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.99 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.99 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.99 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.99 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.99 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.99 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.99 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.99 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.99 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.99 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.99 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.99 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.99 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.99 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.99 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.99 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.99 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.99 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.99 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.99 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.41 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.99 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.407 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.99 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.99 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.99 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.99 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.99 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.99 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.99 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.99 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.99 109.354 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.99 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.99 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.99 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.99 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.99 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.99 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.99 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.99 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.99 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.99 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.99 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.99 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.99 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.99 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.534 ' CG ' HD13 ' D' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.99 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.99 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.431 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.99 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.99 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.99 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.99 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.99 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.99 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.99 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.99 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.99 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.99 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.99 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.99 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.99 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.99 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.99 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.99 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.99 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.99 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.99 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.99 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.99 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.99 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.528 ' CG ' HD13 ' A' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.99 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.532 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.99 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.432 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.99 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.99 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.99 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.99 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.99 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.99 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.99 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.99 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.99 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.99 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.99 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.99 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.99 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.99 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.99 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.99 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.99 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.99 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.99 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.99 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.99 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.99 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.532 ' CG ' HD13 ' B' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.99 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.531 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.99 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.99 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.99 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.99 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.99 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.99 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.99 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.99 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.99 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.99 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.99 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.99 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.99 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.99 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.99 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.99 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.99 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.99 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.99 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.99 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.99 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.99 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.99 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.531 ' CG ' HD13 ' C' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.99 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.534 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.99 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.99 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.99 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.99 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.99 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.99 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.99 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.99 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.99 109.349 -178.871 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.99 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.99 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.99 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.99 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.99 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.99 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.99 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.99 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.99 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.99 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.99 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.99 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.99 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.99 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.99 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.99 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.99 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.99 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.99 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.99 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.99 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.99 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.99 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.99 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.99 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.99 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.99 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.99 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.99 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.99 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.99 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.99 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.99 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.99 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.99 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.99 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.99 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.99 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.99 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.99 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.99 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.99 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.99 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.99 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.99 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.99 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.99 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.99 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.99 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.99 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.99 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.99 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.99 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.99 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.99 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.99 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.99 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.99 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.99 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.99 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.99 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.452 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.99 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.99 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.99 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.99 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.99 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.99 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.99 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.99 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.99 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.99 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.99 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.99 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.99 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.99 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.99 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.99 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.99 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.99 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.99 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.99 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.99 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.99 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.99 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.99 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.99 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.99 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.99 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.99 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.99 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.99 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.99 109.357 -178.893 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.99 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.99 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.99 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.99 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.99 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.99 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.99 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.99 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.99 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.99 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.99 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.99 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.99 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.99 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.99 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.99 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.541 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.99 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.99 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.99 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.99 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.541 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.99 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.99 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.99 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.99 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.99 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.99 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.99 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.99 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.99 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.99 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.99 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.99 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.99 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.99 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.99 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.99 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.99 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.99 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.99 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.99 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.99 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.99 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.99 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.99 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.99 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.99 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.99 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.99 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.99 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.99 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.99 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.99 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.99 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.99 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.99 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.99 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.99 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.99 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.99 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.99 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.99 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.99 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.99 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.99 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.99 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.99 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.537 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.99 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.99 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.99 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.99 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.99 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.99 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.99 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.99 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.99 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.99 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.99 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.99 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.99 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.99 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.99 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.99 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.99 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.99 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.99 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.99 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.99 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.99 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.99 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.99 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.99 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.99 109.34 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.99 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.99 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.99 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.99 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.99 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.99 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.99 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.99 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.99 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.99 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.99 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.99 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.99 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.99 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.99 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.99 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.99 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.99 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.99 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.99 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.99 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.99 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.99 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.99 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.99 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.99 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.99 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.99 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.99 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.99 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.99 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.99 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.99 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.99 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.99 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.99 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.99 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.99 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.99 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.99 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.99 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.99 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.99 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.99 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.99 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.99 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.99 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.99 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.99 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.99 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.99 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.99 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.99 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.99 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.99 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.99 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.99 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.99 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.99 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.99 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.99 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.99 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.99 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.99 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.481 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.99 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.99 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.99 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.99 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.99 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.99 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.99 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.99 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.99 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.99 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.99 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.99 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.99 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.99 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.99 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.99 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.99 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.99 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.99 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.99 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.99 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.99 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.99 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.99 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.495 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.99 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.99 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.99 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.99 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.99 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.99 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.99 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.99 109.316 -178.861 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.99 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.99 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.99 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.99 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.99 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.99 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.99 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.99 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.99 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.99 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.99 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.99 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.99 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.99 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.99 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.99 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.99 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.523 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.99 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.99 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.99 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.99 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.99 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.99 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.99 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.99 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.99 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.99 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.99 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.99 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.99 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.99 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.99 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.99 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.99 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.99 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.99 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.99 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.99 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.99 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.99 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.99 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.99 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.99 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.99 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.99 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.99 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.99 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.99 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.99 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.99 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.99 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.99 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.99 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.99 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.99 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.99 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.99 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.99 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.99 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.99 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.99 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.99 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.99 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.99 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.99 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.99 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.99 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.99 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.99 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.99 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.99 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.99 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.99 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.99 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.99 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.99 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.99 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.99 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.99 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.99 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.99 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.99 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.99 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.99 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.99 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.99 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.99 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.99 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.99 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.99 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.99 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.99 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.99 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.99 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.99 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.99 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.517 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.99 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.99 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.99 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.99 109.335 -178.888 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.99 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.99 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.99 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.99 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.99 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.99 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.99 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.99 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.99 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.99 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.99 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.99 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.99 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.99 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.99 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.99 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.534 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.99 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.99 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.99 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.534 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.99 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.99 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.99 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.99 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.99 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.99 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.99 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.99 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.99 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.99 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.99 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.99 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.99 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.99 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.99 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.99 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.99 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.99 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.99 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.99 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.536 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.99 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.99 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.99 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.536 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.99 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.99 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.99 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.99 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.99 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.99 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.99 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.99 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.99 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.99 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.99 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.99 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.99 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.99 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.99 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.99 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.99 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.99 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.99 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.99 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.99 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.99 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.99 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.99 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.99 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.99 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.99 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.99 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.99 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.99 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.99 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.99 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.99 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.99 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.99 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.99 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.99 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.99 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.99 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.99 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.99 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.99 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.99 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.528 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.99 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.99 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.99 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.528 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.99 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.99 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.99 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.99 109.345 -178.896 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.99 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.99 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.99 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.99 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.99 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.99 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.99 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.99 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.99 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.99 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.99 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.99 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.99 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.99 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.99 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.99 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.99 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.99 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.99 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.99 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.99 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.99 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.99 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.99 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.99 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.99 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.99 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.99 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.99 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.99 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.99 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.99 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.99 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.99 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.99 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.99 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.99 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.513 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.99 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.99 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.99 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.99 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.513 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.99 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.99 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.99 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.99 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.99 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.99 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.99 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.99 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.99 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.99 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.99 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.99 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.99 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.99 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.99 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.99 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.99 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.99 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.503 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.99 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.99 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.99 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.99 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.503 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.99 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.99 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.99 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.99 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.99 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.99 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.99 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.99 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.99 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.99 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.99 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.99 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.99 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.99 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.99 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.99 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.99 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.99 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.501 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.99 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.99 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.99 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.99 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.501 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.99 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.99 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.99 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.99 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.99 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.99 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.99 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.99 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.99 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.99 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.99 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.99 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.99 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.99 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.99 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.99 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.99 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.99 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.99 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.99 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.99 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.99 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.99 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.99 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.99 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.99 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.99 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.99 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.99 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.99 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.99 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.99 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.99 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.99 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.99 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.99 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.99 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.99 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.99 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.99 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.99 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.99 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.99 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.99 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.99 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.99 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.99 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.99 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.99 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.99 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.99 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.99 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.99 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.99 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.99 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.99 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.99 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.99 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.99 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.99 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.99 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.99 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.99 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.99 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.432 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.99 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.99 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.99 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.99 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.99 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.99 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.99 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.99 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.99 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.99 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.99 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.99 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.99 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.99 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.99 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.99 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.99 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.99 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.99 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.99 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.99 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.99 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.99 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.99 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.99 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.99 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.99 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.99 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.99 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.99 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.99 109.322 -178.864 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.99 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.99 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.99 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.99 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.99 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.99 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.99 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.99 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.99 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.99 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.99 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.99 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.99 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.99 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.99 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.99 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.99 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.99 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.99 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.99 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.99 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.99 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.99 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.99 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.99 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.99 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.99 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.99 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.99 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.99 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.99 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.99 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.99 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.99 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.99 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.99 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.99 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.99 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.99 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.99 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.99 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.99 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.99 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.99 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.99 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.99 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.99 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.99 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.99 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.99 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.99 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.99 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.99 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.99 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.99 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.99 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.99 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.99 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.99 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.99 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.99 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.426 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.99 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.99 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.99 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.99 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.99 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.99 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.99 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.99 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.99 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.99 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.99 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.99 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.99 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.99 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.99 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.99 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.99 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.99 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.99 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.99 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.99 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.99 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.99 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.99 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.99 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.99 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.99 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.99 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.99 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.99 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.99 109.324 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.99 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.99 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.99 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.99 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.99 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.99 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.99 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.99 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.99 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.99 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.99 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.99 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.99 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.99 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.99 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.99 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.99 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.99 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.99 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.99 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.99 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.99 109.448 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.99 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.99 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.99 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.99 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.99 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.99 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.99 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.99 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.99 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.99 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.99 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.99 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.99 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.99 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.99 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.99 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.99 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.99 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.99 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' TRP . . . . . 0.407 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.99 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.99 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.99 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.407 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.99 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.99 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.99 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.99 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.99 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.99 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.99 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.99 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.99 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.99 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.99 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.99 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.99 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.99 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.99 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.99 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.99 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.99 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.99 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.99 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' TRP . . . . . 0.407 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.99 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.99 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.99 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.407 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.99 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.99 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.99 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.99 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.99 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.99 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.99 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.99 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.99 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.99 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.99 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.99 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.99 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.99 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.99 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.99 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.99 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.99 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.99 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.99 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 41' ' ' TRP . . . . . 0.404 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.99 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.99 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.99 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.404 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.99 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.99 109.342 -178.877 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.99 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.99 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.99 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.99 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.99 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.99 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.99 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.99 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.99 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.99 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.99 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.99 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.99 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.99 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.99 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.99 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.99 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.433 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.99 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.99 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.99 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.99 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.99 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.99 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.99 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.99 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.99 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.99 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.99 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.99 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.99 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.99 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.99 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.99 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.99 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.99 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.99 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.99 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.99 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.99 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.99 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' TRP . . . . . 0.445 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.99 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.99 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.99 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.99 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.445 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.99 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.99 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.99 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.99 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.99 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.99 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.99 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.99 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.99 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.99 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.99 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.99 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.99 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.99 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.99 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.99 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.99 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.99 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.99 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' TRP . . . . . 0.448 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.99 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.99 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.99 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.99 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.448 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.99 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.99 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.99 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.99 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.99 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.99 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.99 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.99 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.99 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.99 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.99 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.99 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.99 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.99 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.99 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.99 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.99 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.99 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.99 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 41' ' ' TRP . . . . . 0.444 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.99 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.99 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.99 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.99 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.444 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.99 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.99 109.323 -178.875 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.99 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.99 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.99 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.99 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.99 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.99 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.99 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.99 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.99 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.99 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.99 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.99 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.99 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.99 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.99 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.99 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.99 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.99 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.99 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.99 109.22 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.99 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.99 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.99 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.99 109.408 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.99 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.99 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.99 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.99 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.99 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.99 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.99 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.99 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.99 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.99 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.99 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.99 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.99 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.99 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.99 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.99 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.99 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.99 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.99 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.99 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' TRP . . . . . 0.401 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.99 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.99 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.99 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.99 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.401 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.99 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.99 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.99 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.99 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.99 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.99 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.99 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.99 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.99 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.99 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.99 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.99 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.99 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.99 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.99 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.99 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.99 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.99 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.99 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.99 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.99 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' TRP . . . . . 0.405 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.99 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.99 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.99 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.99 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.405 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.99 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.99 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.99 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.99 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.99 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.99 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.99 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.99 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.99 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.99 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.99 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.99 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.99 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.99 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.99 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.99 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.99 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.99 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.99 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.99 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.99 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 41' ' ' TRP . . . . . 0.401 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.99 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.99 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.99 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.99 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.401 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.99 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.99 109.354 -178.867 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.99 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.99 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.99 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.99 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.99 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.99 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.99 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.99 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.99 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.99 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.99 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.99 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.99 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.99 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.99 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.99 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.99 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.455 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.99 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.99 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.99 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.99 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.99 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.99 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.99 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.99 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.99 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.99 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.99 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.99 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.99 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.99 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.99 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.99 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.99 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.99 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.99 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.99 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.99 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.99 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.99 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' TRP . . . . . 0.471 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.99 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.99 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.99 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.99 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.471 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.99 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.99 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.99 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.99 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.99 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.99 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.99 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.99 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.99 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.99 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.99 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.99 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.99 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.99 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.99 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.99 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.99 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.99 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.99 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 41' ' ' TRP . . . . . 0.472 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.99 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.99 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.99 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.99 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.472 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.99 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.99 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.99 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.99 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.99 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.99 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.99 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.99 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.99 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.99 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.99 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.99 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.99 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.99 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.99 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.99 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.99 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.99 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.99 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 41' ' ' TRP . . . . . 0.467 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.99 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.99 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.99 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.99 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.467 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.99 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.99 109.322 -178.881 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.99 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.99 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.99 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.99 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.99 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.99 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.99 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.99 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.99 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.99 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.99 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.99 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.99 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.99 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.99 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.99 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.99 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.99 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.444 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.99 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.99 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.99 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.99 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.444 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.99 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.99 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.99 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.99 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.99 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.99 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.99 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.99 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.99 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.99 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.99 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.99 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.99 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.99 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.99 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.99 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.99 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.99 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.99 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.99 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' TRP . . . . . 0.45 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.99 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.99 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.99 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.99 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.45 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.99 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.99 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.99 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.99 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.99 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.99 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.99 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.99 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.99 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.99 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.99 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.99 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.99 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.99 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.99 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.99 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.99 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.99 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.99 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.99 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' TRP . . . . . 0.442 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.99 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.99 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.99 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.99 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.442 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.99 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.99 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.99 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.99 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.99 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.99 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.99 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.99 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.99 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.99 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.99 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.99 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.99 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.99 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.99 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.99 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.99 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.99 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.99 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.99 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 41' ' ' TRP . . . . . 0.445 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.99 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.99 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.99 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.99 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.445 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.99 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.99 109.309 -178.853 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.99 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.99 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.99 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.99 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.99 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.99 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.99 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.99 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.99 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.99 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.99 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.99 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.99 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.99 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.458 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.99 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.453 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.99 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.99 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.99 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.99 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.99 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.99 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.99 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.99 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.99 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.99 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.99 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.99 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.99 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.99 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.99 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.99 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.99 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.99 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.99 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.99 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.99 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.99 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.99 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.453 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.99 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.459 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.99 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.99 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.99 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.99 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.99 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.99 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.99 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.99 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.99 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.99 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.99 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.99 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.99 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.99 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.99 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.99 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.99 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.99 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.99 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.99 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.99 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.99 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.99 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.459 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.99 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.457 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.99 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.99 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.99 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.99 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.99 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.99 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.99 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.99 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.99 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.99 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.99 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.99 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.99 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.99 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.99 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.99 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.99 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.99 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.99 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.99 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.99 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.99 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.99 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.457 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.99 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.458 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.99 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.99 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.99 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.99 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.99 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.99 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.99 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.99 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.99 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.99 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.99 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.99 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.99 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.99 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.99 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.99 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.99 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.99 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.99 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.99 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.99 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.99 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.99 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.99 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.463 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.99 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.455 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.99 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.99 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.99 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.99 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.99 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.99 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.99 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.99 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.99 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.99 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.99 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.99 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.99 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.99 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.99 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.99 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.99 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.99 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.99 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.99 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.99 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.99 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.99 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.455 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.99 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.46 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.99 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.449 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.99 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.99 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.99 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.99 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.99 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.99 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.99 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.99 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.99 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.99 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.99 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.99 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.99 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.99 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.99 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.99 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.99 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.99 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.99 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.99 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.99 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.99 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.46 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.99 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.465 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.99 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.99 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.99 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.99 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.99 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.99 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.99 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.99 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.99 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.99 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.99 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.99 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.99 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.99 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.99 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.99 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.99 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.99 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.99 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.99 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.99 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.99 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.99 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.465 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.99 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.463 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.99 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.99 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.99 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.99 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.99 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.99 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.99 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.99 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.99 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.99 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.99 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.99 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.99 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.99 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.99 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.99 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.99 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.99 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.99 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.99 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.99 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.99 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.407 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.99 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.403 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.99 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.99 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.99 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.99 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.99 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.99 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.99 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.99 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.99 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.99 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.99 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.99 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.99 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.99 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.99 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.99 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.99 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.99 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.99 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.99 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.99 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.99 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.99 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.403 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.99 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.413 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.99 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.442 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.99 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.99 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.99 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.99 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.99 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.99 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.99 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.99 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.99 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.99 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.99 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.99 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.99 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.99 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.99 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.99 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.99 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.99 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.99 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.99 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.99 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.99 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.413 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.99 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.41 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.99 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.99 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.99 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.99 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.99 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.99 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.99 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.99 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.99 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.99 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.99 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.99 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.99 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.99 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.99 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.99 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.99 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.99 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.99 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.99 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.99 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.99 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.99 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.41 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.99 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.407 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.99 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.99 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.99 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.99 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.99 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.99 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.99 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.99 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.99 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.99 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.99 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.99 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.99 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.99 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.99 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.99 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.99 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.99 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.99 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.99 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.99 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.99 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.99 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.534 ' CG ' HD13 ' D' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.99 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.99 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.431 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.99 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.99 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.99 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.99 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.99 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.99 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.99 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.99 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.99 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.99 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.99 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.99 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.99 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.99 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.99 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.99 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.99 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.99 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.99 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.99 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.99 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.99 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.528 ' CG ' HD13 ' A' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.99 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.532 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.99 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.432 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.99 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.99 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.99 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.99 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.99 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.99 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.99 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.99 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.99 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.99 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.99 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.99 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.99 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.99 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.99 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.99 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.99 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.99 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.99 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.99 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.99 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.99 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.532 ' CG ' HD13 ' B' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.99 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.531 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.99 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.99 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.99 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.99 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.99 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.99 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.99 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.99 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.99 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.99 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.99 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.99 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.99 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.99 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.99 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.99 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.99 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.99 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.99 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.99 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.99 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.99 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.99 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.99 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.531 ' CG ' HD13 ' C' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.99 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.534 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.99 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.99 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.99 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.99 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.99 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.99 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.99 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.99 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.99 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.99 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.99 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.99 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.99 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.99 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.99 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.99 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.99 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.99 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.99 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.99 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.99 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.99 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.99 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.99 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.99 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.99 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.99 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.99 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.99 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.99 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.99 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.99 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.99 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.99 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.99 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.99 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.99 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.99 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.99 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.99 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.99 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.99 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.99 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.99 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.99 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.99 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.99 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.99 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.99 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.99 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.99 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.99 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.99 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.99 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.99 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.99 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.99 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.99 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.99 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.99 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.99 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.99 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.99 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.99 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.99 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.99 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.99 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.99 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.99 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.99 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.452 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.99 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.99 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.99 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.99 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.99 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.99 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.99 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.99 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.99 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.99 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.99 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.99 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.99 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.99 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.99 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.99 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.99 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.99 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.99 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.99 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.99 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.99 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.99 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.99 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.99 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.99 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.99 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.99 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.99 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.99 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.99 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.99 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.99 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.99 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.99 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.99 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.99 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.99 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.99 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.99 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.99 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.99 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.99 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.99 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.99 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.99 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.99 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.541 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.99 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.99 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.99 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.99 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.541 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.99 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.99 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.99 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.99 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.99 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.99 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.99 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.99 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.99 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.99 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.99 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.99 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.99 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.99 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.99 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.99 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.99 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.99 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.99 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.99 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.99 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.99 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.99 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.99 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.99 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.99 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.99 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.99 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.99 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.99 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.99 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.99 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.99 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.99 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.99 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.99 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.99 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.99 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.99 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.99 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.99 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.99 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.99 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.99 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.99 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.99 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.537 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.99 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.99 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.99 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.99 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.99 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.99 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.99 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.99 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.99 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.99 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.99 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.99 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.99 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.99 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.99 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.99 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.99 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.99 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.99 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.99 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.99 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.99 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.99 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.99 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.99 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.99 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.99 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.99 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.99 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.99 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.99 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.99 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.99 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.99 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.99 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.99 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.99 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.99 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.99 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.99 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.99 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.99 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.99 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.99 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.99 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.99 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.99 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.99 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.99 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.99 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.99 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.99 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.99 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.99 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.99 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.99 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.99 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.99 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.99 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.99 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.99 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.99 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.99 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.99 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.99 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.99 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.99 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.99 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.99 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.99 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.99 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.99 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.99 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.99 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.99 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.99 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.99 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.99 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.99 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.99 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.99 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.99 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.99 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.99 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.99 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.99 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.99 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.99 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.99 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.99 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.481 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.99 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.99 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.99 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.99 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.99 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.99 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.99 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.99 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.99 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.99 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.99 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.99 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.99 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.99 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.99 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.99 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.99 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.99 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.99 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.99 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.99 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.99 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.99 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.99 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.99 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.495 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.99 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.99 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.99 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.99 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.99 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.99 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.99 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.99 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.99 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.99 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.99 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.99 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.99 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.99 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.99 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.99 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.99 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.99 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.99 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.99 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.99 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.99 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.99 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.99 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.99 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.523 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.99 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.99 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.99 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.99 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.99 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.99 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.99 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.99 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.99 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.99 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.99 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.99 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.99 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.99 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.99 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.99 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.99 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.99 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.99 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.99 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.99 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.99 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.99 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.99 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.99 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.99 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.99 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.99 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.99 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.99 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.99 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.99 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.99 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.99 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.99 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.99 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.99 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.99 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.99 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.99 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.99 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.99 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.99 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.99 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.99 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.99 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.99 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.99 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.99 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.99 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.99 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.99 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.99 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.99 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.99 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.99 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.99 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.99 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.99 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.99 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.99 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.99 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.99 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.99 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.99 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.99 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.99 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.99 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.99 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.99 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.99 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.99 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.99 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.99 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.99 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.99 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.99 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.99 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.99 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.517 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.99 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.99 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.99 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.99 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.99 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.99 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.99 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.99 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.99 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.99 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.99 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.99 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.99 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.99 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.99 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.99 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.99 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.99 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.99 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.99 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.534 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.99 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.99 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.99 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.534 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.99 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.99 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.99 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.99 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.99 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.99 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.99 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.99 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.99 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.99 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.99 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.99 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.99 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.99 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.99 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.99 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.99 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.99 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.99 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.99 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.536 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.99 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.99 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.99 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.536 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.99 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.99 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.99 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.99 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.99 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.99 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.99 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.99 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.99 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.99 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.99 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.99 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.99 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.99 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.99 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.99 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.99 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.99 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.99 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.99 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.99 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.99 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.99 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.99 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.99 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.99 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.99 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.99 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.99 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.99 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.99 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.99 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.99 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.99 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.99 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.99 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.99 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.99 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.99 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.99 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.99 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.99 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.99 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.528 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.99 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.99 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.99 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.528 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.99 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.99 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.99 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.99 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.99 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.99 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.99 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.99 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.99 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.99 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.99 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.99 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.99 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.99 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.99 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.99 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.99 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.99 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.99 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.99 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.99 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.99 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.99 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.99 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.99 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.99 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.99 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.99 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.99 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.99 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.99 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.99 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.99 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.99 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.99 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.99 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.99 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.99 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.99 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.99 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.99 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.513 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.99 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.99 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.99 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.99 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.513 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.99 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.99 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.99 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.99 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.99 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.99 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.99 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.99 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.99 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.99 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.99 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.99 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.99 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.99 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.99 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.99 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.99 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.99 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.503 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.99 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.99 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.99 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.99 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.503 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.99 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.99 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.99 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.99 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.99 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.99 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.99 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.99 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.99 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.99 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.99 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.99 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.99 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.99 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.99 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.99 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.99 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.99 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.99 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.501 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.99 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.99 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.99 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.99 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.501 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.99 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.99 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.99 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.99 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.99 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.99 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.99 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.99 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.99 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.99 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.99 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.99 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.99 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.99 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.99 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.99 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.99 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.99 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.99 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.99 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.99 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.99 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.99 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.99 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.99 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.99 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.99 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.99 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.99 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.99 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.99 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.99 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.99 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.99 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.99 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.99 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.99 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.99 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.99 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.99 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.99 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.99 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.99 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.99 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.99 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.99 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.99 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.99 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.99 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.99 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.99 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.99 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.99 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.99 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.99 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.99 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.99 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.99 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.99 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.99 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.99 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.99 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.99 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.99 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.99 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.432 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.99 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.99 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.99 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.99 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.99 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.99 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.99 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.99 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.99 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.99 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.99 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.99 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.99 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.99 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.99 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.99 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.99 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.99 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.99 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.99 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.99 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.99 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.99 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.99 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.99 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.99 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.99 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.99 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.99 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.99 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.99 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.99 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.99 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.99 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.99 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.99 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.99 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.99 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.99 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.99 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.99 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.99 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.99 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.99 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.99 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.99 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.99 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.99 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.99 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.99 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.99 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.99 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.99 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.99 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.99 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.99 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.99 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.99 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.99 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.99 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.99 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.99 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.99 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.99 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.99 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.99 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.99 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.99 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.99 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.99 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.99 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.99 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.99 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.99 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.99 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.99 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.99 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.99 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.99 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.99 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.99 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.99 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.99 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.99 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.99 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.99 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.99 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.99 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.99 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.99 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.99 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.99 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.99 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.426 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.99 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.99 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.99 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.99 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.99 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.99 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.99 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.99 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.99 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.99 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.99 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.99 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.99 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.99 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.99 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.99 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.99 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.99 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.99 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.99 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.99 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.99 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.99 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.99 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.99 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.99 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.99 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.99 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.99 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.99 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.99 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.99 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.99 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.99 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.99 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.99 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.99 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.99 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.99 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.99 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.99 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.99 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.99 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.99 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.99 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.99 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.99 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.99 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.99 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.99 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.99 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.99 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.99 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.99 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.99 109.448 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.99 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.99 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.99 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.99 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.99 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.99 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.99 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.99 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.99 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.99 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.99 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.99 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.99 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.99 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.99 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.99 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.99 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.99 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.99 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' TRP . . . . . 0.407 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.99 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.99 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.99 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.407 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.99 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.99 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.99 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.99 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.99 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.99 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.99 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.99 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.99 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.99 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.99 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.99 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.99 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.99 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.99 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.99 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.99 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.99 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.99 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.99 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' TRP . . . . . 0.407 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.99 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.99 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.99 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.407 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.99 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.99 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.99 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.99 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.99 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.99 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.99 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.99 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.99 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.99 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.99 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.99 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.99 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.99 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.99 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.99 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.99 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.99 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.99 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.99 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.99 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 41' ' ' TRP . . . . . 0.404 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.99 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.99 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.99 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.99 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.404 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.99 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.99 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.99 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.99 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.99 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.99 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.99 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.99 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.99 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.99 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.99 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.99 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.99 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.99 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.99 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.99 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.99 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.99 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.99 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.433 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.99 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.99 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.99 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.99 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.99 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.99 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.99 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.99 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.99 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.99 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.99 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.99 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.99 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.99 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.99 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.99 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.99 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.99 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.99 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.99 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.99 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.99 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.99 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' TRP . . . . . 0.445 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.99 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.99 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.99 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.99 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.445 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.99 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.99 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.99 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.99 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.99 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.99 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.99 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.99 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.99 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.99 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.99 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.99 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.99 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.99 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.99 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.99 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.99 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.99 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.99 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' TRP . . . . . 0.448 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.99 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.99 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.99 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.99 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.448 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.99 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.99 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.99 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.99 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.99 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.99 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.99 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.99 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.99 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.99 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.99 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.99 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.99 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.99 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.99 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.99 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.99 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.99 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.99 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.99 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 41' ' ' TRP . . . . . 0.444 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.99 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.99 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.99 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.99 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.444 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.99 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.99 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.99 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.99 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.99 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.99 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.99 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.99 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.99 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.99 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.99 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.99 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.99 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.99 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.99 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.99 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.99 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.99 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.99 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.99 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.99 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.99 109.22 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.99 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.99 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.99 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.99 109.408 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.99 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.99 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.99 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.99 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.99 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.99 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.99 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.99 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.99 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.99 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.99 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.99 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.99 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.99 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.99 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.99 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.99 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.99 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.99 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.99 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' TRP . . . . . 0.401 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.99 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.99 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.99 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.99 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.401 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.99 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.99 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.99 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.99 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.99 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.99 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.99 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.99 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.99 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.99 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.99 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.99 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.99 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.99 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.99 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.99 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.99 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.99 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.99 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.99 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.99 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' TRP . . . . . 0.405 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.99 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.99 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.99 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.99 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.405 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.99 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.99 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.99 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.99 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.99 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.99 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.99 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.99 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.99 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.99 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.99 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.99 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.99 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.99 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.99 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.99 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.99 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.99 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.99 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.99 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.99 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 41' ' ' TRP . . . . . 0.401 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.99 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.99 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.99 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.99 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.401 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.99 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.99 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.99 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.99 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.99 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.99 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.99 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.99 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.99 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.99 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.99 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.99 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.99 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.99 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.99 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.99 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.99 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.99 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.99 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.455 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.99 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.99 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.99 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.99 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.99 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.99 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.99 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.99 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.99 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.99 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.99 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.99 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.99 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.99 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.99 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.99 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.99 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.99 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.99 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.99 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.99 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.99 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.99 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' TRP . . . . . 0.471 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.99 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.99 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.99 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.99 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.471 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.99 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.99 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.99 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.99 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.99 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.99 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.99 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.99 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.99 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.99 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.99 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.99 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.99 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.99 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.99 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.99 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.99 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.99 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.99 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 41' ' ' TRP . . . . . 0.472 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.99 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.99 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.99 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.99 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.472 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.99 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.99 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.99 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.99 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.99 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.99 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.99 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.99 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.99 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.99 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.99 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.99 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.99 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.99 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.99 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.99 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.99 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.99 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.99 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.99 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 41' ' ' TRP . . . . . 0.467 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.99 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.99 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.99 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.99 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.467 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.99 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.99 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.99 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.99 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.99 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.99 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.99 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.99 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.99 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.99 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.99 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.99 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.99 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.99 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.99 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.99 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.99 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.99 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.99 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.99 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.444 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.99 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.99 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.99 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.99 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.444 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.99 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.99 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.99 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.99 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.99 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.99 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.99 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.99 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.99 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.99 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.99 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.99 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.99 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.99 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.99 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.99 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.99 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.99 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.99 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.99 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' TRP . . . . . 0.45 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.99 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.99 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.99 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.99 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.45 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.99 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.99 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.99 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.99 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.99 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.99 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.99 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.99 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.99 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.99 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.99 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.99 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.99 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.99 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.99 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.99 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.99 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.99 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.99 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.99 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' TRP . . . . . 0.442 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.99 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.99 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.99 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.99 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.442 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.99 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.99 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.99 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.99 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.99 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.99 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.99 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.99 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.99 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.99 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.99 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.99 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.99 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.99 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.99 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.99 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.99 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.99 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.99 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.99 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.99 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 41' ' ' TRP . . . . . 0.445 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.99 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.99 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.99 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.99 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.445 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.99 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.99 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.458 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.453 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.453 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.459 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.459 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.457 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.457 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.458 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.463 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.455 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.455 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.46 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.449 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.46 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.465 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.465 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.463 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.407 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.403 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.403 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.413 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.442 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.413 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.41 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.41 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.407 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.534 ' CG ' HD13 ' D' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.431 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.528 ' CG ' HD13 ' A' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.532 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.432 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.532 ' CG ' HD13 ' B' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.531 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.531 ' CG ' HD13 ' C' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.534 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.452 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.541 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.541 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.537 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.481 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.495 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.523 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.517 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.534 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.534 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.536 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.536 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.528 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.528 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.513 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.513 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.503 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.503 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.501 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.501 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.432 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.426 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . 0.407 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.407 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . 0.407 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.407 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . 0.404 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.404 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.433 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . 0.445 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.445 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . 0.448 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.448 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . 0.444 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.444 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . 0.401 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.401 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . 0.405 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.405 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . 0.401 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.401 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.455 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . 0.471 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.471 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . 0.472 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.472 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . 0.467 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.467 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.444 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.444 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . 0.45 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.45 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . 0.442 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.442 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . 0.445 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.445 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.458 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.453 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.453 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.459 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.462 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.459 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.457 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.342 0.592 . . . . 99.989999999999995 111.979 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -123.82 -167.72 1.67 Allowed 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -88.81 150.24 45.35 Favored Pre-proline 0 C--N 1.358 0.974 0 CA-C-O 118.151 -0.928 . . . . 99.989999999999995 108.565 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.11 -22.89 14.15 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 112.935 -163.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -69.14 -42.85 75.44 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.384 173.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.06 -45.84 79.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.302 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.53 -44.77 79.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.301 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.3 -42.76 96.2 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.205 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.01 82.8 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.469 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.3 m -62.62 -46.73 86.92 Favored 'General case' 0 C--N 1.26 -3.298 0 O-C-N 124.474 1.109 . . . . 99.989999999999995 109.215 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.7 -38.38 82.55 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.414 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.46 -46.62 96.2 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.241 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.327 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.85 -9.77 47.68 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.367 -1.493 . . . . 99.989999999999995 109.367 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -94.41 -46.71 13.52 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.309 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.371 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.87 -43.94 97.74 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.263 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.457 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.3 t-160 -63.91 -26.25 68.52 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 124.816 1.246 . . . . 99.989999999999995 109.885 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.458 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.92 -45.35 58.61 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.336 -0.616 . . . . 99.989999999999995 109.336 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -63.42 -44.74 99.04 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.298 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.193 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -61.57 -43.44 98.85 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.25 0.969 . . . . 99.989999999999995 109.342 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -66.01 -43.67 86.99 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.319 1.012 . . . . 99.989999999999995 109.199 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.5 mt -67.12 -42.79 88.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.228 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.04 -36.64 84.24 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.317 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.95 -39.05 83.48 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.359 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.51 -43.88 88.7 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 124.341 1.026 . . . . 99.989999999999995 109.411 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.1 mt . . . . . 0 C--N 1.262 -3.227 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.334 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.463 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.455 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.446 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.455 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.46 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.449 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.46 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.465 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.987 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.24 -167.89 1.63 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.683 -1.969 . . . . 99.989999999999995 105.683 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -89.0 150.8 46.04 Favored Pre-proline 0 C--N 1.358 0.949 0 CA-C-O 118.147 -0.93 . . . . 99.989999999999995 108.581 -173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.08 -23.17 13.92 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.63 2.22 . . . . 99.989999999999995 112.913 -163.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.14 -42.58 75.79 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.61 2.364 . . . . 99.989999999999995 109.436 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -69.75 -46.1 75.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.329 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -69.26 -44.92 80.19 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.299 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.72 96.39 Favored 'General case' 0 C--N 1.26 -3.292 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.202 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.59 84.5 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 124.483 1.114 . . . . 99.989999999999995 109.468 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.95 -47.37 85.19 Favored 'General case' 0 C--N 1.26 -3.288 0 O-C-N 124.462 1.101 . . . . 99.989999999999995 109.252 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.97 -38.4 82.69 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.42 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.24 -46.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.304 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.64 -9.67 45.96 Favored Glycine 0 C--N 1.262 -3.575 0 N-CA-C 109.352 -1.499 . . . . 99.989999999999995 109.352 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -94.87 -46.1 13.4 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.265 0 O-C-N 117.675 -3.25 . . . . 99.989999999999995 109.357 173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.97 -44.63 97.08 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.228 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.465 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.2 t-160 -63.97 -26.4 68.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.783 1.233 . . . . 99.989999999999995 109.947 -177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.463 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.67 -45.37 59.22 Favored 'General case' 0 C--O 1.205 -1.268 0 N-CA-C 109.305 -0.628 . . . . 99.989999999999995 109.305 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.06 -44.4 99.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.337 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.212 -178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.2 mt -61.59 -44.03 97.76 Favored 'General case' 0 C--N 1.26 -3.29 0 O-C-N 124.275 0.984 . . . . 99.989999999999995 109.385 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.13 -42.92 88.48 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.36 1.037 . . . . 99.989999999999995 109.223 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.46 -43.34 87.52 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.187 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.231 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -63.37 -35.62 81.01 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.39 1.057 . . . . 99.989999999999995 109.329 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -68.44 -39.33 81.57 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.31 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.57 -43.22 90.46 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.387 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--N 1.262 -3.226 0 O-C-N 124.401 1.063 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.407 ' CG ' HD13 ' D' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.403 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.403 ' CG ' HD13 ' A' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.413 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.442 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.413 ' CG ' HD13 ' B' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.41 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -121.93 -166.76 1.44 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.714 -1.958 . . . . 99.989999999999995 105.714 174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -90.24 150.75 43.73 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 118.16 -0.924 . . . . 99.989999999999995 108.543 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.16 -23.24 13.73 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.657 2.238 . . . . 99.989999999999995 112.894 -163.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.16 -42.98 75.18 Favored 'General case' 0 C--O 1.204 -1.29 0 C-N-CA 127.682 2.393 . . . . 99.989999999999995 109.359 173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -69.97 -45.75 75.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.441 1.088 . . . . 99.989999999999995 109.349 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.98 -44.9 81.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.314 1.009 . . . . 99.989999999999995 109.284 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.293 0.996 . . . . 99.989999999999995 109.206 -178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.18 -36.65 84.77 Favored 'General case' 0 C--N 1.262 -3.238 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.426 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -61.94 -46.96 87.01 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.439 1.087 . . . . 99.989999999999995 109.267 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.18 -38.18 82.04 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.322 1.014 . . . . 99.989999999999995 109.409 -178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.49 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 O-C-N 124.445 1.09 . . . . 99.989999999999995 109.328 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.41 -9.84 45.46 Favored Glycine 0 C--N 1.262 -3.576 0 N-CA-C 109.371 -1.492 . . . . 99.989999999999995 109.371 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.0 mt -95.24 -45.88 13.29 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 O-C-N 117.728 -3.219 . . . . 99.989999999999995 109.429 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.24 -45.18 95.61 Favored 'General case' 0 C--N 1.262 -3.235 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.196 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.41 ' CG ' HD13 ' C' ' 38' ' ' LEU . 23.0 t-160 -63.71 -26.07 68.49 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.789 1.235 . . . . 99.989999999999995 110.031 -177.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.407 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.7 tp -72.64 -45.2 60.16 Favored 'General case' 0 C--O 1.204 -1.316 0 N-CA-C 109.298 -0.63 . . . . 99.989999999999995 109.298 178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.444 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -63.41 -44.39 98.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.206 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.63 -43.44 98.86 Favored 'General case' 0 C--N 1.259 -3.339 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 109.343 -178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -66.23 -43.72 85.83 Favored 'General case' 0 C--N 1.262 -3.198 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.231 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -67.23 -43.51 88.22 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.404 1.065 . . . . 99.989999999999995 109.227 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -63.6 -36.06 82.55 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.364 1.04 . . . . 99.989999999999995 109.345 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.74 -40.08 84.18 Favored 'General case' 0 C--N 1.262 -3.202 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.351 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -65.18 -43.75 90.67 Favored 'General case' 0 C--N 1.26 -3.283 0 O-C-N 124.358 1.036 . . . . 99.989999999999995 109.414 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.235 0 O-C-N 124.479 1.112 . . . . 99.989999999999995 109.354 -178.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.534 ' CG ' HD13 ' D' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD13 ' CG ' ' B' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.431 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.528 ' CG ' HD13 ' A' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.532 HD13 ' CG ' ' C' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.432 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.532 ' CG ' HD13 ' B' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.531 HD13 ' CG ' ' D' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.43 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.302 0.572 . . . . 99.989999999999995 111.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.59 -167.19 1.48 Allowed 'General case' 0 C--N 1.354 0.784 0 N-CA-C 105.669 -1.974 . . . . 99.989999999999995 105.669 174.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -89.57 150.34 44.14 Favored Pre-proline 0 C--N 1.358 0.965 0 CA-C-O 118.103 -0.951 . . . . 99.989999999999995 108.589 -173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -75.09 -22.86 14.21 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.676 2.251 . . . . 99.989999999999995 112.895 -163.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.3 tp -70.39 -43.15 70.64 Favored 'General case' 0 C--O 1.205 -1.271 0 C-N-CA 127.63 2.372 . . . . 99.989999999999995 109.351 174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -69.64 -46.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.175 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.355 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.1 t -69.47 -44.75 79.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.361 1.038 . . . . 99.989999999999995 109.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.67 97.18 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.23 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.44 84.16 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.396 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.51 -47.36 85.98 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.253 -178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.56 -37.82 81.04 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.22 0 O-C-N 124.261 0.975 . . . . 99.989999999999995 109.385 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.95 -46.32 96.75 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.229 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.276 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.88 -9.7 47.54 Favored Glycine 0 C--N 1.262 -3.581 0 N-CA-C 109.351 -1.5 . . . . 99.989999999999995 109.351 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.52 -45.32 13.23 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.256 0 O-C-N 117.713 -3.227 . . . . 99.989999999999995 109.356 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.78 -45.35 94.69 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.248 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.531 ' CG ' HD13 ' C' ' 38' ' ' LEU . 22.9 t-160 -63.42 -26.04 68.55 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 124.824 1.25 . . . . 99.989999999999995 110.106 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.534 HD13 ' CG ' ' A' ' 37' ' ' HIS . 58.6 tp -72.32 -44.2 63.02 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.11 -44.04 97.57 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.303 0 O-C-N 124.286 0.991 . . . . 99.989999999999995 109.204 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.65 -43.61 98.53 Favored 'General case' 0 C--N 1.259 -3.33 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.34 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -66.78 -43.2 84.62 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.229 -178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.85 -43.31 89.7 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.366 1.041 . . . . 99.989999999999995 109.233 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -64.18 -36.78 85.19 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.322 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.89 -40.51 87.77 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.368 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.37 -43.19 95.28 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.392 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.262 -3.222 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.349 -178.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.452 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -121.03 -166.86 1.4 Allowed 'General case' 0 C--N 1.355 0.808 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -89.06 149.1 42.52 Favored Pre-proline 0 C--N 1.359 0.992 0 CA-C-O 118.13 -0.938 . . . . 99.989999999999995 108.558 -173.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.0 -23.46 13.77 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.706 2.27 . . . . 99.989999999999995 112.967 -163.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.47 -43.6 69.44 Favored 'General case' 0 C--O 1.205 -1.248 0 C-N-CA 127.619 2.368 . . . . 99.989999999999995 109.4 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -69.87 -46.21 74.57 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.465 1.103 . . . . 99.989999999999995 109.293 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.56 -44.88 79.34 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.24 0 O-C-N 124.336 1.023 . . . . 99.989999999999995 109.297 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.32 -41.16 96.56 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.344 1.027 . . . . 99.989999999999995 109.271 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -36.41 84.08 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.412 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -61.1 -46.91 88.69 Favored 'General case' 0 C--N 1.261 -3.279 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.284 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.41 -38.09 81.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 O-C-N 124.379 1.049 . . . . 99.989999999999995 109.45 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.43 -45.98 97.53 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 O-C-N 124.41 1.069 . . . . 99.989999999999995 109.323 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.36 -8.94 40.48 Favored Glycine 0 C--N 1.262 -3.542 0 N-CA-C 109.393 -1.483 . . . . 99.989999999999995 109.393 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -95.37 -45.03 13.28 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 O-C-N 117.737 -3.213 . . . . 99.989999999999995 109.408 173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.1 -44.81 94.56 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.438 1.086 . . . . 99.989999999999995 109.23 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.74 -26.47 68.71 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.931 1.292 . . . . 99.989999999999995 110.163 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.4 -43.89 63.27 Favored 'General case' 0 C--O 1.204 -1.33 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.6 mt -63.98 -44.43 97.88 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.304 0 O-C-N 124.327 1.017 . . . . 99.989999999999995 109.163 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.1 mt -62.0 -44.0 97.65 Favored 'General case' 0 C--N 1.26 -3.315 0 O-C-N 124.213 0.946 . . . . 99.989999999999995 109.403 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.11 -43.08 83.37 Favored 'General case' 0 C--N 1.263 -3.195 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.227 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.28 -43.57 87.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.24 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.22 -37.08 86.21 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.331 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.34 -40.59 89.96 Favored 'General case' 0 C--N 1.261 -3.256 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.338 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.34 -42.37 96.29 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.398 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.223 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.357 -178.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.541 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.541 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.537 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.333 0.587 . . . . 99.989999999999995 112.011 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -121.08 -167.07 1.43 Allowed 'General case' 0 C--N 1.355 0.805 0 N-CA-C 105.68 -1.97 . . . . 99.989999999999995 105.68 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.49 150.17 45.93 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 118.113 -0.946 . . . . 99.989999999999995 108.602 -173.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.02 -24.25 12.97 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 112.958 -163.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.8 tp -69.91 -44.03 70.49 Favored 'General case' 0 C--O 1.205 -1.289 0 C-N-CA 127.621 2.368 . . . . 99.989999999999995 109.382 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -68.89 -46.29 79.36 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 O-C-N 124.444 1.09 . . . . 99.989999999999995 109.308 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.77 -45.21 78.05 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.382 1.051 . . . . 99.989999999999995 109.295 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.9 97.83 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.347 1.029 . . . . 99.989999999999995 109.197 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.3 -36.28 83.59 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.413 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.82 -46.34 90.92 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.412 1.07 . . . . 99.989999999999995 109.266 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.71 -38.17 82.0 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.44 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.62 -46.59 96.23 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.251 0 O-C-N 124.455 1.097 . . . . 99.989999999999995 109.278 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.07 -8.95 38.38 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 77.8 mt -95.23 -45.57 13.3 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 O-C-N 117.717 -3.226 . . . . 99.989999999999995 109.396 173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -60.32 -44.52 95.4 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.389 1.056 . . . . 99.989999999999995 109.251 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -61.84 -26.49 68.16 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.959 1.303 . . . . 99.989999999999995 110.185 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.73 -44.58 61.5 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 109.365 -0.605 . . . . 99.989999999999995 109.365 179.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.539 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -63.9 -43.98 97.91 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.3 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.181 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -62.36 -44.49 96.35 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.338 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.46 -43.54 80.81 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.2 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.36 -43.43 87.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.329 1.018 . . . . 99.989999999999995 109.241 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.539 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -64.79 -36.63 84.94 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.318 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.05 -40.84 91.28 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.345 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.65 -43.34 97.05 Favored 'General case' 0 C--N 1.261 -3.27 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.408 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.221 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.34 -178.861 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.494 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.481 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.332 0.587 . . . . 99.989999999999995 111.994 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -121.66 -167.36 1.51 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 105.667 -1.975 . . . . 99.989999999999995 105.667 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -88.11 149.74 45.9 Favored Pre-proline 0 C--N 1.358 0.961 0 CA-C-O 118.124 -0.941 . . . . 99.989999999999995 108.588 -173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.06 -25.06 12.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.717 2.278 . . . . 99.989999999999995 112.934 -163.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -69.9 -44.15 70.29 Favored 'General case' 0 C--O 1.205 -1.284 0 C-N-CA 127.624 2.37 . . . . 99.989999999999995 109.383 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.68 -46.49 79.68 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.164 0 O-C-N 124.452 1.095 . . . . 99.989999999999995 109.38 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.91 -44.6 78.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.217 0 O-C-N 124.359 1.037 . . . . 99.989999999999995 109.263 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.36 -42.21 98.33 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.239 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.79 -36.27 83.35 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.466 1.104 . . . . 99.989999999999995 109.459 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -60.95 -46.35 91.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.232 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.7 -38.34 82.44 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.48 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.11 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.324 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.19 -8.96 39.34 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.35 -1.5 . . . . 99.989999999999995 109.35 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -95.42 -45.79 13.25 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.278 0 O-C-N 117.782 -3.187 . . . . 99.989999999999995 109.381 173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.15 -44.09 95.23 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.247 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.39 -26.31 68.4 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.941 1.297 . . . . 99.989999999999995 110.147 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.55 -44.75 61.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.495 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -64.32 -44.13 97.23 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.283 0 O-C-N 124.325 1.016 . . . . 99.989999999999995 109.217 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.13 -44.43 96.65 Favored 'General case' 0 C--N 1.259 -3.334 0 O-C-N 124.274 0.984 . . . . 99.989999999999995 109.34 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.9 t90 -67.8 -43.38 79.84 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.217 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.57 -42.98 90.8 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.183 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.276 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.5 mt -64.7 -36.16 83.37 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.338 1.024 . . . . 99.989999999999995 109.348 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.57 -40.74 89.12 Favored 'General case' 0 C--N 1.261 -3.246 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.324 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.24 96.33 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.387 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 C--N 1.261 -3.251 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.316 -178.861 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.523 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.524 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.524 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -122.81 -167.85 1.65 Allowed 'General case' 0 C--N 1.354 0.803 0 N-CA-C 105.668 -1.975 . . . . 99.989999999999995 105.668 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.55 149.73 47.12 Favored Pre-proline 0 C--N 1.358 0.968 0 CA-C-O 118.14 -0.934 . . . . 99.989999999999995 108.585 -173.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.08 -25.17 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.682 2.254 . . . . 99.989999999999995 112.892 -163.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.5 tp -69.9 -43.63 71.36 Favored 'General case' 0 C--O 1.206 -1.235 0 C-N-CA 127.657 2.383 . . . . 99.989999999999995 109.377 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.86 -46.49 79.14 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.495 1.122 . . . . 99.989999999999995 109.337 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.75 -44.26 79.32 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.305 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.351 1.032 . . . . 99.989999999999995 109.23 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.31 -35.84 81.71 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.45 1.094 . . . . 99.989999999999995 109.437 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.5 -46.15 91.21 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.23 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.7 mt -64.18 -37.76 80.71 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.324 1.015 . . . . 99.989999999999995 109.427 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.47 -46.53 96.39 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.249 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.311 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.78 -8.77 42.59 Favored Glycine 0 C--N 1.262 -3.564 0 N-CA-C 109.354 -1.499 . . . . 99.989999999999995 109.354 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.05 -45.96 13.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.316 0 O-C-N 117.71 -3.229 . . . . 99.989999999999995 109.408 173.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.54 -43.46 97.16 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 124.446 1.091 . . . . 99.989999999999995 109.191 -178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.77 -26.15 68.57 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 110.086 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.54 -44.66 61.86 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 109.291 -0.633 . . . . 99.989999999999995 109.291 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -64.78 -44.41 96.43 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.34 0 O-C-N 124.323 1.014 . . . . 99.989999999999995 109.198 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.78 -43.8 98.13 Favored 'General case' 0 C--N 1.26 -3.302 0 O-C-N 124.247 0.967 . . . . 99.989999999999995 109.371 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -67.62 -44.37 78.17 Favored 'General case' 0 C--N 1.263 -3.176 0 O-C-N 124.333 1.021 . . . . 99.989999999999995 109.241 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.4 mt -66.63 -42.26 89.51 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.252 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.517 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.5 mt -65.54 -36.57 84.18 Favored 'General case' 0 C--N 1.262 -3.213 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.375 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.54 -40.69 89.23 Favored 'General case' 0 C--N 1.262 -3.232 0 O-C-N 124.341 1.025 . . . . 99.989999999999995 109.342 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.96 -43.74 94.86 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.424 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.335 -178.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.534 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.534 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.536 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.536 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.53 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.8 p . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 112.001 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.37 -167.42 1.56 Allowed 'General case' 0 C--N 1.354 0.796 0 N-CA-C 105.684 -1.969 . . . . 99.989999999999995 105.684 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -86.75 149.88 49.37 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.127 -0.94 . . . . 99.989999999999995 108.588 -173.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.09 -25.41 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.66 2.24 . . . . 99.989999999999995 112.926 -163.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -70.36 -43.72 69.61 Favored 'General case' 0 C--O 1.205 -1.241 0 C-N-CA 127.607 2.363 . . . . 99.989999999999995 109.366 174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.13 -46.55 81.18 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.355 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.1 t -69.39 -44.11 80.43 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.23 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.2 98.93 Favored 'General case' 0 C--N 1.261 -3.262 0 O-C-N 124.337 1.023 . . . . 99.989999999999995 109.261 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.16 79.4 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.428 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -61.61 -46.21 90.8 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.26 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -63.98 -38.08 81.47 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 109.447 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -61.45 -46.8 95.84 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.248 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.327 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.35 -8.93 40.29 Favored Glycine 0 C--N 1.262 -3.551 0 N-CA-C 109.376 -1.489 . . . . 99.989999999999995 109.376 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -95.92 -46.77 13.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.733 -3.216 . . . . 99.989999999999995 109.38 173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.4 -42.78 96.65 Favored 'General case' 0 C--N 1.261 -3.249 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.229 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -63.49 -26.05 68.54 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 124.842 1.257 . . . . 99.989999999999995 110.115 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.0 -44.92 62.68 Favored 'General case' 0 C--O 1.205 -1.281 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.528 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.8 mt -65.28 -44.45 94.94 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.48 -43.84 98.15 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.221 0.951 . . . . 99.989999999999995 109.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -68.2 -44.06 76.7 Favored 'General case' 0 C--N 1.262 -3.201 0 O-C-N 124.348 1.03 . . . . 99.989999999999995 109.219 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.66 -42.56 89.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.209 0 O-C-N 124.338 1.023 . . . . 99.989999999999995 109.247 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.528 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.3 mt -65.24 -35.29 80.58 Favored 'General case' 0 C--N 1.262 -3.229 0 O-C-N 124.315 1.009 . . . . 99.989999999999995 109.303 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.12 -41.67 85.79 Favored 'General case' 0 C--N 1.261 -3.244 0 O-C-N 124.326 1.016 . . . . 99.989999999999995 109.333 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.51 -43.22 97.83 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.292 0.995 . . . . 99.989999999999995 109.425 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.262 -3.232 0 O-C-N 124.434 1.084 . . . . 99.989999999999995 109.345 -178.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.514 ' CD1' HG22 ' A' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.513 HG22 ' CD1' ' B' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.513 ' CD1' HG22 ' B' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.503 HG22 ' CD1' ' C' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.503 ' CD1' HG22 ' C' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.5 p . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -123.11 -166.78 1.5 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 105.643 -1.984 . . . . 99.989999999999995 105.643 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -86.98 149.93 48.86 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 118.156 -0.926 . . . . 99.989999999999995 108.587 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -75.08 -25.86 11.33 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.685 2.256 . . . . 99.989999999999995 112.917 -163.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.2 tp -70.6 -43.38 69.46 Favored 'General case' 0 C--O 1.205 -1.245 0 C-N-CA 127.608 2.363 . . . . 99.989999999999995 109.405 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -67.42 -46.62 83.12 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 O-C-N 124.47 1.106 . . . . 99.989999999999995 109.371 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.55 -44.65 82.74 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.228 0 O-C-N 124.391 1.057 . . . . 99.989999999999995 109.254 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.04 99.69 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.29 0.994 . . . . 99.989999999999995 109.24 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -35.84 80.91 Favored 'General case' 0 C--N 1.262 -3.222 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.447 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -61.68 -46.27 90.45 Favored 'General case' 0 C--N 1.261 -3.268 0 O-C-N 124.407 1.067 . . . . 99.989999999999995 109.308 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.2 mt -64.49 -37.75 80.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.235 0 O-C-N 124.312 1.007 . . . . 99.989999999999995 109.403 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.71 -47.02 94.86 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.271 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.361 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.59 -9.14 43.1 Favored Glycine 0 C--N 1.262 -3.558 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.34 -46.85 12.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.245 0 O-C-N 117.719 -3.224 . . . . 99.989999999999995 109.406 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -60.39 -43.49 96.59 Favored 'General case' 0 C--N 1.261 -3.277 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.219 -178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -64.03 -25.33 68.07 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 110.107 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -71.94 -44.82 62.98 Favored 'General case' 0 C--O 1.204 -1.299 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.501 HG22 ' CD1' ' D' ' 43' ' ' LEU . 94.7 mt -65.18 -43.47 95.5 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.363 1.039 . . . . 99.989999999999995 109.189 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -61.49 -43.76 98.28 Favored 'General case' 0 C--N 1.26 -3.311 0 O-C-N 124.289 0.993 . . . . 99.989999999999995 109.391 -178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.6 t90 -67.83 -43.95 78.39 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.385 1.053 . . . . 99.989999999999995 109.226 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -66.6 -42.54 90.02 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.202 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.213 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.501 ' CD1' HG22 ' D' ' 39' ' ' ILE . 84.6 mt -65.41 -35.3 80.52 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.363 1.04 . . . . 99.989999999999995 109.308 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.39 -41.36 85.11 Favored 'General case' 0 C--N 1.261 -3.243 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.311 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.48 -43.86 96.07 Favored 'General case' 0 C--N 1.26 -3.289 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.409 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.261 -3.259 0 O-C-N 124.437 1.086 . . . . 99.989999999999995 109.324 -178.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.429 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.432 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 112.003 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -122.89 -166.5 1.45 Allowed 'General case' 0 C--N 1.355 0.811 0 N-CA-C 105.693 -1.966 . . . . 99.989999999999995 105.693 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -87.58 150.11 47.87 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 118.116 -0.945 . . . . 99.989999999999995 108.592 -173.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.07 -25.33 11.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.674 2.25 . . . . 99.989999999999995 112.912 -163.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.32 -43.08 67.72 Favored 'General case' 0 C--O 1.205 -1.26 0 C-N-CA 127.571 2.348 . . . . 99.989999999999995 109.407 173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -67.38 -46.54 83.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.473 1.108 . . . . 99.989999999999995 109.366 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.38 -43.87 83.91 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.208 0 O-C-N 124.328 1.017 . . . . 99.989999999999995 109.293 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.67 -42.93 99.6 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.342 1.026 . . . . 99.989999999999995 109.224 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.24 -36.18 81.21 Favored 'General case' 0 C--N 1.262 -3.205 0 O-C-N 124.372 1.045 . . . . 99.989999999999995 109.423 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.5 m -62.59 -46.67 87.24 Favored 'General case' 0 C--N 1.261 -3.269 0 O-C-N 124.396 1.06 . . . . 99.989999999999995 109.306 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.32 -38.05 81.54 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.185 0 O-C-N 124.307 1.005 . . . . 99.989999999999995 109.418 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.88 -46.41 96.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 O-C-N 124.409 1.068 . . . . 99.989999999999995 109.305 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.03 -8.85 37.62 Favored Glycine 0 C--N 1.262 -3.561 0 N-CA-C 109.376 -1.49 . . . . 99.989999999999995 109.376 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -96.2 -47.34 12.92 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.27 0 O-C-N 117.704 -3.233 . . . . 99.989999999999995 109.327 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -60.06 -43.79 95.17 Favored 'General case' 0 C--N 1.261 -3.273 0 O-C-N 124.43 1.082 . . . . 99.989999999999995 109.203 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -63.62 -25.97 68.47 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 124.84 1.256 . . . . 99.989999999999995 110.167 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.96 -44.39 63.64 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 109.322 -0.622 . . . . 99.989999999999995 109.322 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.8 mt -66.04 -43.0 92.66 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.256 0.973 . . . . 99.989999999999995 109.226 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.59 -44.2 97.45 Favored 'General case' 0 C--N 1.26 -3.322 0 O-C-N 124.266 0.978 . . . . 99.989999999999995 109.357 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.47 -42.95 82.17 Favored 'General case' 0 C--N 1.261 -3.24 0 O-C-N 124.371 1.044 . . . . 99.989999999999995 109.214 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -66.19 -42.56 91.34 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.214 0 O-C-N 124.39 1.056 . . . . 99.989999999999995 109.211 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.4 mt -65.53 -35.86 82.11 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.353 1.033 . . . . 99.989999999999995 109.325 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.3 -41.81 84.76 Favored 'General case' 0 C--N 1.261 -3.266 0 O-C-N 124.331 1.02 . . . . 99.989999999999995 109.368 -178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -64.21 -43.92 93.53 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.382 -178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.247 0 O-C-N 124.419 1.074 . . . . 99.989999999999995 109.322 -178.864 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' B' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' B' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.426 ' O ' ' HG ' ' C' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' C' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.361 0.601 . . . . 99.989999999999995 111.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.8 m -124.5 -165.7 1.41 Allowed 'General case' 0 C--N 1.355 0.833 0 N-CA-C 105.651 -1.981 . . . . 99.989999999999995 105.651 174.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.66 150.55 48.66 Favored Pre-proline 0 C--N 1.358 0.953 0 CA-C-O 118.055 -0.974 . . . . 99.989999999999995 108.609 -173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.07 -25.3 11.89 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.661 2.241 . . . . 99.989999999999995 112.904 -163.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -71.2 -43.16 67.95 Favored 'General case' 0 C--O 1.205 -1.282 0 C-N-CA 127.658 2.383 . . . . 99.989999999999995 109.393 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.65 -46.08 86.83 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.482 1.114 . . . . 99.989999999999995 109.379 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -68.35 -44.26 83.71 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.18 0 O-C-N 124.378 1.049 . . . . 99.989999999999995 109.319 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.51 98.87 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.298 0.999 . . . . 99.989999999999995 109.231 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.46 -36.25 81.86 Favored 'General case' 0 C--N 1.262 -3.22 0 O-C-N 124.421 1.076 . . . . 99.989999999999995 109.408 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.37 -47.42 84.24 Favored 'General case' 0 C--N 1.26 -3.304 0 O-C-N 124.393 1.058 . . . . 99.989999999999995 109.246 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.63 -38.05 81.65 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.193 0 O-C-N 124.332 1.02 . . . . 99.989999999999995 109.437 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.2 -46.56 96.38 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.225 0 O-C-N 124.394 1.059 . . . . 99.989999999999995 109.306 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.6 -8.12 37.9 Favored Glycine 0 C--N 1.262 -3.563 0 N-CA-C 109.383 -1.487 . . . . 99.989999999999995 109.383 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -47.48 12.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.257 0 O-C-N 117.722 -3.222 . . . . 99.989999999999995 109.38 173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.5 -43.75 93.28 Favored 'General case' 0 C--N 1.261 -3.28 0 O-C-N 124.436 1.085 . . . . 99.989999999999995 109.212 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -63.6 -27.03 68.96 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 124.825 1.25 . . . . 99.989999999999995 110.149 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.11 -43.82 64.16 Favored 'General case' 0 C--O 1.204 -1.292 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.433 ' O ' ' HG ' ' D' ' 43' ' ' LEU . 94.7 mt -66.07 -43.41 92.39 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.306 0 O-C-N 124.304 1.002 . . . . 99.989999999999995 109.194 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -61.18 -44.52 97.18 Favored 'General case' 0 C--N 1.26 -3.309 0 O-C-N 124.287 0.992 . . . . 99.989999999999995 109.38 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.35 -43.13 82.25 Favored 'General case' 0 C--N 1.262 -3.219 0 O-C-N 124.307 1.004 . . . . 99.989999999999995 109.243 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -66.12 -42.76 91.92 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.189 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.265 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' D' ' 39' ' ' ILE . 84.3 mt -65.49 -34.94 79.44 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.345 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.75 -41.15 83.81 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.346 1.029 . . . . 99.989999999999995 109.315 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.98 -43.79 94.67 Favored 'General case' 0 C--N 1.261 -3.258 0 O-C-N 124.354 1.034 . . . . 99.989999999999995 109.43 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.324 -178.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . 0.407 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.407 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . 0.407 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.407 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 111.997 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -124.12 -165.71 1.4 Allowed 'General case' 0 C--N 1.355 0.832 0 N-CA-C 105.709 -1.959 . . . . 99.989999999999995 105.709 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -88.2 151.12 48.53 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.125 -0.941 . . . . 99.989999999999995 108.577 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -75.03 -24.94 12.28 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.71 2.273 . . . . 99.989999999999995 112.951 -163.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -71.39 -43.71 66.33 Favored 'General case' 0 C--O 1.205 -1.256 0 C-N-CA 127.641 2.376 . . . . 99.989999999999995 109.354 174.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.8 t -66.3 -46.43 87.15 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 O-C-N 124.456 1.098 . . . . 99.989999999999995 109.33 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.51 -44.45 83.01 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.231 0 O-C-N 124.343 1.027 . . . . 99.989999999999995 109.269 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.66 -42.47 98.95 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.377 1.048 . . . . 99.989999999999995 109.25 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.36 -36.24 81.65 Favored 'General case' 0 C--N 1.261 -3.252 0 O-C-N 124.42 1.075 . . . . 99.989999999999995 109.435 -178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -47.66 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.457 1.098 . . . . 99.989999999999995 109.252 -178.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.24 -38.04 81.46 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 O-C-N 124.283 0.99 . . . . 99.989999999999995 109.462 -178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.71 -46.49 96.41 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.226 0 O-C-N 124.38 1.05 . . . . 99.989999999999995 109.297 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.73 -8.49 40.69 Favored Glycine 0 C--N 1.261 -3.595 0 N-CA-C 109.341 -1.503 . . . . 99.989999999999995 109.341 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -96.11 -46.94 13.04 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.313 0 O-C-N 117.661 -3.258 . . . . 99.989999999999995 109.418 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -59.33 -43.59 92.71 Favored 'General case' 0 C--N 1.262 -3.221 0 O-C-N 124.427 1.079 . . . . 99.989999999999995 109.236 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -62.76 -27.6 69.4 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.907 1.283 . . . . 99.989999999999995 110.189 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.46 -43.85 63.16 Favored 'General case' 0 C--O 1.205 -1.266 0 N-CA-C 109.345 -0.613 . . . . 99.989999999999995 109.345 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.31 -43.36 91.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.281 0 O-C-N 124.276 0.985 . . . . 99.989999999999995 109.214 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.0 mt -60.49 -44.38 96.02 Favored 'General case' 0 C--N 1.26 -3.306 0 O-C-N 124.248 0.968 . . . . 99.989999999999995 109.331 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . 0.404 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.7 t90 -67.92 -42.62 80.81 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.207 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.0 mt -66.02 -43.45 92.54 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.203 0 O-C-N 124.403 1.065 . . . . 99.989999999999995 109.192 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.1 -36.21 83.59 Favored 'General case' 0 C--N 1.261 -3.241 0 O-C-N 124.371 1.045 . . . . 99.989999999999995 109.343 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.34 -41.43 85.21 Favored 'General case' 0 C--N 1.262 -3.236 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.345 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.404 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.46 -44.12 95.38 Favored 'General case' 0 C--N 1.26 -3.294 0 O-C-N 124.384 1.053 . . . . 99.989999999999995 109.448 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--N 1.262 -3.225 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.342 -178.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.433 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.433 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . 0.445 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.445 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . 0.448 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.448 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.354 0.597 . . . . 99.989999999999995 111.999 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.1 m -124.33 -165.77 1.41 Allowed 'General case' 0 C--N 1.355 0.829 0 N-CA-C 105.625 -1.991 . . . . 99.989999999999995 105.625 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.79 151.26 49.69 Favored Pre-proline 0 C--N 1.358 0.972 0 CA-C-O 118.136 -0.935 . . . . 99.989999999999995 108.594 -173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -25.69 11.56 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.686 2.257 . . . . 99.989999999999995 112.94 -163.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.65 -43.09 66.69 Favored 'General case' 0 C--O 1.205 -1.283 0 C-N-CA 127.645 2.378 . . . . 99.989999999999995 109.358 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.59 -46.61 89.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.201 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.311 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.02 -43.84 81.67 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.415 1.072 . . . . 99.989999999999995 109.249 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.7 99.16 Favored 'General case' 0 C--N 1.261 -3.259 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.221 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.89 -35.53 80.34 Favored 'General case' 0 C--N 1.261 -3.274 0 O-C-N 124.443 1.089 . . . . 99.989999999999995 109.396 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.8 m -62.12 -47.33 85.09 Favored 'General case' 0 C--N 1.26 -3.313 0 O-C-N 124.471 1.107 . . . . 99.989999999999995 109.267 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.35 -37.82 80.94 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.215 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.437 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -61.57 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.233 0 O-C-N 124.37 1.044 . . . . 99.989999999999995 109.338 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -66.32 -7.93 41.77 Favored Glycine 0 C--N 1.262 -3.574 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.3 mt -96.56 -47.16 12.88 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.282 0 O-C-N 117.745 -3.209 . . . . 99.989999999999995 109.358 173.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.09 -43.51 91.83 Favored 'General case' 0 C--N 1.262 -3.225 0 O-C-N 124.445 1.091 . . . . 99.989999999999995 109.275 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.59 -27.66 69.35 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.926 1.29 . . . . 99.989999999999995 110.146 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.6 tp -72.51 -44.3 62.4 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 109.319 -0.622 . . . . 99.989999999999995 109.319 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.62 -44.04 90.1 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.287 0 O-C-N 124.297 0.998 . . . . 99.989999999999995 109.213 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.59 -44.62 93.29 Favored 'General case' 0 C--N 1.26 -3.286 0 O-C-N 124.309 1.005 . . . . 99.989999999999995 109.368 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . 0.444 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.07 -42.63 84.36 Favored 'General case' 0 C--N 1.262 -3.216 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 109.183 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.77 -42.97 93.5 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.212 0 O-C-N 124.365 1.041 . . . . 99.989999999999995 109.231 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.6 mt -65.16 -36.23 83.58 Favored 'General case' 0 C--N 1.262 -3.233 0 O-C-N 124.317 1.011 . . . . 99.989999999999995 109.367 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.83 -41.18 83.41 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.373 1.045 . . . . 99.989999999999995 109.368 -178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.444 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.95 -43.84 94.6 Favored 'General case' 0 C--N 1.261 -3.257 0 O-C-N 124.349 1.031 . . . . 99.989999999999995 109.407 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 C--N 1.262 -3.216 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 109.323 -178.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . 0.401 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.401 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . 0.405 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.405 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.342 0.591 . . . . 99.989999999999995 111.976 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.4 m -123.57 -166.13 1.43 Allowed 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.702 -1.962 . . . . 99.989999999999995 105.702 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -87.42 152.07 51.78 Favored Pre-proline 0 C--N 1.358 0.962 0 CA-C-O 118.11 -0.948 . . . . 99.989999999999995 108.597 -173.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -75.06 -26.58 10.68 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.722 2.281 . . . . 99.989999999999995 112.915 -163.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.9 tp -71.95 -42.67 66.34 Favored 'General case' 0 C--O 1.204 -1.302 0 C-N-CA 127.585 2.354 . . . . 99.989999999999995 109.419 173.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.6 t -65.67 -46.44 89.26 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 O-C-N 124.468 1.105 . . . . 99.989999999999995 109.345 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 76.0 t -69.71 -43.95 79.66 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.197 0 O-C-N 124.367 1.042 . . . . 99.989999999999995 109.286 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.2 98.43 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.345 1.028 . . . . 99.989999999999995 109.259 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.22 -35.48 80.46 Favored 'General case' 0 C--N 1.261 -3.242 0 O-C-N 124.429 1.081 . . . . 99.989999999999995 109.403 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.28 -47.23 85.24 Favored 'General case' 0 C--N 1.26 -3.308 0 O-C-N 124.398 1.061 . . . . 99.989999999999995 109.251 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.0 -37.92 81.48 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 O-C-N 124.318 1.011 . . . . 99.989999999999995 109.477 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.7 mt -60.71 -46.67 95.54 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.239 0 O-C-N 124.453 1.096 . . . . 99.989999999999995 109.312 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.4 -7.63 34.0 Favored Glycine 0 C--N 1.262 -3.569 0 N-CA-C 109.356 -1.498 . . . . 99.989999999999995 109.356 -178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.4 mt -96.46 -46.49 12.95 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.308 0 O-C-N 117.679 -3.248 . . . . 99.989999999999995 109.365 173.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.0 tp -59.55 -43.56 93.49 Favored 'General case' 0 C--N 1.262 -3.227 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.208 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -62.36 -28.25 69.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.971 1.308 . . . . 99.989999999999995 110.113 -177.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.8 tp -73.04 -44.5 60.66 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 123.281 0.632 . . . . 99.989999999999995 109.311 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.58 -44.02 90.26 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.309 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.217 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.15 -44.17 95.18 Favored 'General case' 0 C--N 1.26 -3.316 0 O-C-N 124.303 1.002 . . . . 99.989999999999995 109.369 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . 0.401 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.8 t90 -67.23 -43.21 82.56 Favored 'General case' 0 C--N 1.262 -3.234 0 O-C-N 124.392 1.057 . . . . 99.989999999999995 109.22 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.1 mt -65.57 -43.13 94.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.219 0 O-C-N 124.35 1.031 . . . . 99.989999999999995 109.198 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -64.96 -36.46 84.47 Favored 'General case' 0 C--N 1.262 -3.223 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.357 -178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.4 -41.26 85.24 Favored 'General case' 0 C--N 1.262 -3.231 0 O-C-N 124.362 1.039 . . . . 99.989999999999995 109.326 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.401 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -63.86 -44.34 93.42 Favored 'General case' 0 C--N 1.26 -3.285 0 O-C-N 124.375 1.047 . . . . 99.989999999999995 109.408 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--N 1.261 -3.253 0 O-C-N 124.414 1.071 . . . . 99.989999999999995 109.354 -178.867 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.455 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.455 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . 0.471 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.471 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . 0.472 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.472 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.359 0.599 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.9 m -123.17 -166.53 1.47 Allowed 'General case' 0 C--N 1.355 0.806 0 N-CA-C 105.666 -1.976 . . . . 99.989999999999995 105.666 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -87.17 151.84 52.05 Favored Pre-proline 0 C--N 1.359 0.981 0 CA-C-O 118.107 -0.949 . . . . 99.989999999999995 108.578 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.04 -26.12 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 99.989999999999995 112.931 -163.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 tp -72.0 -42.97 65.81 Favored 'General case' 0 C--O 1.205 -1.287 0 C-N-CA 127.603 2.361 . . . . 99.989999999999995 109.38 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 87.5 t -65.86 -46.16 89.39 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 O-C-N 124.545 1.153 . . . . 99.989999999999995 109.357 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -69.66 -44.46 79.4 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 O-C-N 124.403 1.064 . . . . 99.989999999999995 109.296 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.31 -42.58 98.9 Favored 'General case' 0 C--N 1.261 -3.272 0 O-C-N 124.316 1.01 . . . . 99.989999999999995 109.196 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.39 80.06 Favored 'General case' 0 C--N 1.262 -3.239 0 O-C-N 124.432 1.082 . . . . 99.989999999999995 109.427 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.7 m -62.38 -47.4 84.31 Favored 'General case' 0 C--N 1.261 -3.278 0 O-C-N 124.467 1.105 . . . . 99.989999999999995 109.302 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 87.0 mt -65.15 -37.77 81.03 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.218 0 O-C-N 124.365 1.04 . . . . 99.989999999999995 109.468 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.66 -46.03 96.51 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 O-C-N 124.453 1.095 . . . . 99.989999999999995 109.333 -178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.92 -7.74 38.1 Favored Glycine 0 C--N 1.262 -3.572 0 N-CA-C 109.334 -1.506 . . . . 99.989999999999995 109.334 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.4 -47.01 12.96 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 117.742 -3.211 . . . . 99.989999999999995 109.393 173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.99 -43.06 91.42 Favored 'General case' 0 C--N 1.262 -3.237 0 O-C-N 124.422 1.076 . . . . 99.989999999999995 109.237 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -62.72 -28.47 69.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.975 1.31 . . . . 99.989999999999995 110.16 -177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -72.58 -44.52 61.92 Favored 'General case' 0 C--O 1.205 -1.262 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.315 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.8 mt -66.73 -43.87 89.78 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.311 0 O-C-N 124.311 1.007 . . . . 99.989999999999995 109.229 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 80.3 mt -59.91 -44.28 94.37 Favored 'General case' 0 C--N 1.259 -3.327 0 O-C-N 124.242 0.964 . . . . 99.989999999999995 109.395 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . 0.467 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.5 t90 -67.72 -43.09 80.83 Favored 'General case' 0 C--N 1.262 -3.207 0 O-C-N 124.308 1.005 . . . . 99.989999999999995 109.226 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.3 mt -64.51 -42.9 96.56 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.173 0 O-C-N 124.381 1.05 . . . . 99.989999999999995 109.246 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.34 -36.78 85.07 Favored 'General case' 0 C--N 1.262 -3.217 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.313 -178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -66.79 -41.41 87.69 Favored 'General case' 0 C--N 1.262 -3.228 0 O-C-N 124.317 1.01 . . . . 99.989999999999995 109.319 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.467 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.05 -44.77 91.47 Favored 'General case' 0 C--N 1.261 -3.281 0 O-C-N 124.331 1.019 . . . . 99.989999999999995 109.413 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 C--N 1.261 -3.243 0 O-C-N 124.428 1.08 . . . . 99.989999999999995 109.322 -178.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.444 ' CZ2' ' HD2' ' A' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.444 ' HD2' ' CZ2' ' A' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . 0.45 ' CZ2' ' HD2' ' B' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.45 ' HD2' ' CZ2' ' B' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . 0.442 ' CZ2' ' HD2' ' C' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.442 ' HD2' ' CZ2' ' C' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 92.4 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.363 0.601 . . . . 99.989999999999995 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.2 m -122.63 -166.47 1.43 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.65 -1.982 . . . . 99.989999999999995 105.65 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -87.32 151.58 51.3 Favored Pre-proline 0 C--N 1.359 0.986 0 CA-C-O 118.104 -0.95 . . . . 99.989999999999995 108.577 -173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -75.06 -26.29 10.95 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.701 2.267 . . . . 99.989999999999995 112.941 -163.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 45.7 tp -71.83 -43.82 64.92 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 127.594 2.358 . . . . 99.989999999999995 109.403 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.6 -46.39 89.64 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.186 0 O-C-N 124.447 1.092 . . . . 99.989999999999995 109.384 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.73 -44.18 79.42 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.381 1.051 . . . . 99.989999999999995 109.32 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.24 -42.61 98.91 Favored 'General case' 0 C--N 1.261 -3.263 0 O-C-N 124.31 1.006 . . . . 99.989999999999995 109.266 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.73 80.25 Favored 'General case' 0 C--N 1.261 -3.26 0 O-C-N 124.484 1.115 . . . . 99.989999999999995 109.438 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -62.12 -47.52 84.21 Favored 'General case' 0 C--N 1.26 -3.31 0 O-C-N 124.397 1.061 . . . . 99.989999999999995 109.271 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.75 -38.24 82.2 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.211 0 O-C-N 124.33 1.019 . . . . 99.989999999999995 109.453 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 14.9 mt -60.9 -46.9 95.57 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.243 0 O-C-N 124.419 1.075 . . . . 99.989999999999995 109.36 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.24 -7.27 31.11 Favored Glycine 0 C--N 1.262 -3.567 0 N-CA-C 109.328 -1.509 . . . . 99.989999999999995 109.328 -178.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.2 mt -96.28 -46.89 12.99 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.279 0 O-C-N 117.687 -3.243 . . . . 99.989999999999995 109.347 173.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 61.4 tp -59.41 -43.85 92.94 Favored 'General case' 0 C--N 1.262 -3.206 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 109.235 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -62.41 -27.67 69.25 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 125.009 1.324 . . . . 99.989999999999995 110.121 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -72.79 -44.87 61.0 Favored 'General case' 0 C--O 1.205 -1.274 0 C-N-CA 123.291 0.636 . . . . 99.989999999999995 109.325 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 94.7 mt -66.2 -43.62 91.81 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 O-C-N 124.357 1.035 . . . . 99.989999999999995 109.176 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 79.7 mt -60.02 -44.17 94.79 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 124.283 0.989 . . . . 99.989999999999995 109.38 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . 0.445 ' CZ2' ' HD2' ' D' ' 45' ' ' ARG . 71.6 t90 -67.93 -42.6 80.77 Favored 'General case' 0 C--N 1.263 -3.189 0 O-C-N 124.282 0.989 . . . . 99.989999999999995 109.197 -178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.02 -42.31 94.31 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.172 0 O-C-N 124.383 1.052 . . . . 99.989999999999995 109.235 -178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -65.22 -36.44 84.16 Favored 'General case' 0 C--N 1.261 -3.261 0 O-C-N 124.384 1.052 . . . . 99.989999999999995 109.315 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 -40.96 87.16 Favored 'General case' 0 C--N 1.261 -3.245 0 O-C-N 124.356 1.035 . . . . 99.989999999999995 109.314 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.445 ' HD2' ' CZ2' ' D' ' 41' ' ' TRP . 5.5 mmp_? -64.04 -44.86 91.24 Favored 'General case' 0 C--N 1.261 -3.276 0 O-C-N 124.388 1.055 . . . . 99.989999999999995 109.392 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 68.3 mt . . . . . 0 C--N 1.262 -3.236 0 O-C-N 124.481 1.113 . . . . 99.989999999999995 109.309 -178.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' 308 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_